Entry |
|
Name |
Varespladib (USAN/INN) |
Formula |
C21H20N2O5
|
Exact mass |
380.1372
|
Mol weight |
380.39
|
Structure |

|
Simcomp |
|
Remark |
|
Efficacy |
Antidyslipidemia, Secretory phospholipase A2 (sPLA2) inhibitor |
Comment |
Treatment of dyslipidemia
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
PLA2G7 (LP-PLA2)
D08107 Varespladib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 C1b C 18.5690 -19.4105
2 C8y C 19.8300 -20.1111
3 N4y N 18.5690 -18.0094
4 C8x C 19.8300 -21.5122
5 C8x C 21.0209 -22.2127
6 C8x C 22.2118 -21.5122
7 C8x C 22.2118 -20.1111
8 C8x C 21.0209 -19.4105
9 C8y C 19.6899 -17.1688
10 C8y C 19.2695 -15.8377
11 C8y C 17.8684 -15.8377
12 C8y C 17.4481 -17.1688
13 C8y C 16.9577 -14.8569
14 C8x C 15.5566 -15.1372
15 C8x C 15.1363 -16.4682
16 C8x C 16.1171 -17.5190
17 C1b C 20.8808 -17.8693
18 C1a C 22.1418 -17.1688
19 C5a C 19.9701 -14.6468
20 C5a C 21.3712 -14.6468
21 N1a N 22.0717 -13.4558
22 O5a O 19.2695 -13.4558
23 O5a O 22.0717 -15.9078
24 O2a O 17.3780 -13.5259
25 C1b C 16.3973 -12.4751
26 C6a C 15.0272 -12.8204
27 O6a O 14.0582 -11.8219
28 O6a O 14.6494 -14.1515
BOND 30
1 1 2 1
2 1 3 1
3 2 4 2
4 4 5 1
5 5 6 2
6 6 7 1
7 7 8 2
8 2 8 1
9 3 9 1
10 9 10 2
11 10 11 1
12 11 12 1
13 3 12 1
14 11 13 2
15 13 14 1
16 14 15 2
17 15 16 1
18 12 16 2
19 9 17 1
20 17 18 1
21 10 19 1
22 19 20 1
23 20 21 1
24 19 22 2
25 20 23 2
26 13 24 1
27 24 25 1
28 25 26 1
29 26 27 2
30 26 28 1
|